F-18 Fluorodeoxyglucose

DRUG2 trials

Sponsors

National Cancer Institute (NCI), Boston Children's Hospital

Conditions

Childhood NeoplasmSarcoma

Phase 2

Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas

CompletedNCT00043979

National Cancer Institute (NCI)Sarcoma

Start: 2002-09-19End: 2011-12-14Updated: 2017-05-31

Phase 4

Biokinetics Study for F-18 FDG in Pediatric Molecular Imaging

WithdrawnNCT03107325

Boston Children's HospitalChildhood Neoplasm

Start: 2019-02-01End: 2020-10-01Updated: 2020-10-06